Symtuza
Symtuza is a medicine authorised by Swissmedic under authorisation number 66779. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 29 May 2019 and the authorisation is valid without a time limit. ATC code J05AR22 places the medicine in the group Antivirals for systemic use.
| Authorisation number | 66779 |
|---|---|
| Name | Symtuza |
| Full name | Symtuza, Filmtabletten |
| Authorisation holder | Janssen-Cilag AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J05AR22 |
| First authorisation | 29 May 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Symtuza, Filmtabletten | A | 29 May 2019 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | J05AR22 | 08.03.0. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Symtuza authorised in Switzerland?
Yes. Symtuza is authorised by Swissmedic under authorisation number 66779, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Symtuza have?
Symtuza is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Symtuza?
The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.